Xtant Medical price to free cash flow XTNT

Market value divided by free cash flow over the last twelve months, since 2019.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 8.0×; Aug 2026
8-year median: 21.0×
8-year range: 6.6× to 76.1×
Peer median: 10.9×

Xtant Medical's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Aug 2026, at 8.0×.

On the days it had one over the last 8 years, its median was 21.0×, from 6.6× in Apr 2026 to 76.1× in Apr 2019.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	8.0×	6.6×	20.2×
2025	21.0×	16.0×	21.0×
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	19.8×	15.9×	22.6×
2019	23.7×	22.3×	76.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Xtant Medical's size, closest first, today.

Company	Price to free cash flow
XTNTXtant Medical	n/m
NEPHNephros	n/m
APTAlpha Pro Tech	9.7×
KEQUKewaunee Scientific	8.7×
PDEXPro DEX	29.5×
UTMDUtah Medical Products	20.6×
INFUInfuSystem	12.1×
EMBCEmbecta	2.3×
Peer median	10.9×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Xtant Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.